BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

F2G Ltd 

The Manchester Incubator Building
Grafton Street
Manchester    M139XX  United Kingdom
Phone: 44-0-161-606-7250 Fax: 44-0-161-606-7251


SEARCH JOBS


Industry
Biotechnology






 Company News
F2G Ltd and the University of Manchester Announce a New €6.1 Million Project to Develop New Antifungal Agents to Treat Resistant Fungal Infections 6/25/2013 10:14:17 AM    More...
F2G Ltd Appoints Ian Nicholson as CEO 3/18/2013 9:05:45 AM    More...
F2G Ltd Appoints John H. Rex to Board of Directors 2/19/2013 12:36:54 PM    More...
F2G Ltd Raises $30 Million to Fund Pre-Clinical and Clinical Development of Novel Anti-Fungal Compounds 9/5/2012 6:40:47 AM    More...
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors 9/13/2010 2:39:41 PM    More...
F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors 2/24/2010 2:19:37 PM    More...
F2G Ltd Initiates Phase I Clinical Trial for FG3622 7/7/2009 10:55:22 AM    More...
F2G Ltd Announces Key Appointment and a Consolidation of the Management Team 2/12/2009 11:59:23 AM    More...
F2G Ltd Announces Presentations at 48th Interscience Conference on Antimicrobial Agents and Chemotherapy(ICAAC) 10/24/2008 9:21:12 AM    More...
F2G Ltd Completes £6.3 Million Financing Round to Fund Preclinical and Clinical Development 8/19/2008 9:13:40 AM    More...
12

//-->